Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
This study is currently recruiting participants.
Verified August 2011 by National Cancer Institute (NCI)
Study NCT00886691
Information provided by National Cancer Institute (NCI)
First Received on April 22, 2009.
Last Updated on August 25, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
